Teva Sues Sandoz, Novartis Over Copaxone ANDA
Teva Pharmaceuticals Industries Ltd. has filed suit accusing Sandoz Inc. and parent company Novartis AG of using confidential information to prepare a generic version of Teva's multiple sclerosis drug Copaxone....To view the full article, register now.
Already a subscriber? Click here to view full article